Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Cardiovascular Risk and Bone Loss in HIV
NCT01218802Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Feb 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in heart disease, osteoporosis, sponsored by University Hospitals Cleveland Medical Center. Started Feb 2011; status: completed.
02
Drugs
rosuvastatin
03
Conditions
heart diseaseosteoporosis
Beyond the preview
Go deeper on NCT01218802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218802.